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Objective: To investigate associations between plasma calcium and future
incidence of hypertension in a healthy population.
Methods: We used prospective data from Ansung and Ansan cohorts (nZ 10,038)
of the Korean Genome and Epidemiology Study. Data from baseline (2001e02) to
the fourth study (2007e08) were used. After excluding hypertensive cases at
baseline, missing data, and outliers, 5560 participants were analyzed. Propensity
scores for having higher plasma calcium (2.37 mmol/L) were created for each
participant. After propensity score matching (1:1 nearest neighbor matching
within caliper), 2153 pairs were left for analysis. Factors that were significantly
different between the lower and higher plasma calcium groups before matching
either became nonsignificant or the difference decreased in size.
Results: Using multivariable Cox proportional hazard models with robust stan-
dard errors accounting for clustering of matched pairs, higher plasma calcium
was associated with higher incidence of hypertension (adjusted HR, 1.24; robust
95%CI, 1.07e1.43). Among those with higher plasma calcium, low dietary calcium
intake increased the development of hypertension, but the effect was not
significant. Sensitivity analysis showed that our results were robust to hidden
bias.
Conclusions: Plasma calcium was positively associated with incidence of
hypertension. These results expand on cross-sectional associations between
hypercalcemia and the metabolic syndrome, and extend the link to future risk of
hypertension.ibuted under the terms of the Creative Commons Attribution Non-Commercial License
y-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in
is properly cited.
ol and Prevention. Published by Elsevier. All rights reserved.
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Hypertension is a growing public health problem [1]
and a strong risk factor for cardiovascular disease
worldwide [2,3]. The prevalence of hypertension in
Korea was reported to be 28.9% among men and 15.9%
among women [4].
There have been some studies reporting associations
between plasma calcium and hypertension; moreover,
acute hypercalcemia [5,6] and chronic hypercalcemia
due to hyperparathyroidism or other causes [7,8] are
often accompanied by hypertension, whereas acute
hypocalcemia is known to induce hypotension [9,10].
The mechanisms involved in calcium-mediated blood
pressure (BP) control are incompletely understood, but
peripheral vasoconstriction appears to play a role [6].
Recently, a link between plasma calcium and para-
thyroid hormone (PTH) with metabolic syndrome was
suggested in a cross-sectional study [11]. This link may
be translated into an association between hypercalcemia
and future risk of hypertension; however, few prospec-
tive data on the topic are available, particularly in the
general population.
We analyzed data from two well-established, pop-
ulation-based, prospective cohorts of the Korean
Genome and Epidemiology Study (KoGES), first
established in 2001, to investigate the effects of plasma
calcium on incidence of hypertension.2. Subjects and Methods
2.1. Study population
KoGES is an ongoing series of prospective cohort
studies conducted by the Korea Centers for Disease
Control and Prevention. The participants comprise
Korean adults aged 4069 years; the total number of
participants is expected to reach 300,000 by 2012. The
community-based cohorts in Ansung (a rural area) and
in Ansan (an urban community) were the first cohorts
of KoGES, established in 2001. The baseline survey
was conducted from May 2001 to February 2003 in
10,038 participants, including 4763 men and 5275
women; follow-up surveys have been performed every
other year since then. Among the 10,038 participants
at baseline, subjects who were either hypertensive
(including those on antihypertensive medication)
(nZ 3142) or failed to return to follow-up (nZ 1147)
were excluded from this analysis. An additional 189
patients who were outliers or had missing values with
respect to the plasma calcium level were excluded. In
this study, data from the baseline study to the third
(2007e08) follow-up survey were used, which
encompassed 6 years of follow-up. This study was
approved by the institutional review board or the Korea
Centers for Disease Control and Prevention, and fol-
lowed the ethical principles for medical researchinvolving human subjects outlined in the Helsinki
declaration.
2.2. Blood pressure measurements
Measurements for blood pressure and other clinical
and laboratory tests, as well as various definitions, are
described in the Supplementary Methods online.
2.3. Statistical analysis
First, plasma calcium levels were classified into
quartiles, namely Q1 thru Q4: Q1 for <2.28 (mean,
2.17) mmol/L, Q2 for 2.282.37 (mean, 2.33) mmol/L,
Q3 for 2.372.44 (mean, 2.41) mmol/L, and Q4 for
2.44 mmol/L (mean, 2.50) mmol/L. We then
computed incidence ratio of hypertension within
different quartiles of plasma calcium level using person-
time of follow-up from baseline examination to diag-
nosis of hypertension at a subsequent examination, or
day of the last follow-up examination, whichever came
first.
To reduce impact of selection bias and potential
confounding we performed adjustments for significant
differences in characteristics of participants by propen-
sity score matching [12,13]. Detailed methods for
propensity score matching and other statistical analyses
are described in the Supplementary Methods online.3. Results
3.1. Baseline characteristics and incidence of
hypertension according to plasma calcium
A total of 5560 participants (male/female, 2750/2810)
were included in the analysis. Baseline characteristics of
the study participants are presented in Supplementary
Table 1. Participants with higher baseline plasma calcium
level had positive correlations with older age, smoking,
rural area of residence, systolic BP, presence of micro-
albuminuria, and serum total cholesterol and tri-
acylglyceride (TG). There were inverse correlations
between plasma calcium and BMI, serum glucose, and
high-density lipoprotein cholesterol (HDL-C) levels.
Plasma calcium increased with higher dietary calcium
intake, but the trend in the association was not significant.
During the 6 years of follow-up, we identified 1017
incident cases of hypertension. The incidence rates of
hypertension per 1000 person-years for quartiles Q1 thru
Q4 of plasma calcium levels were 6.1, 6.2, 7.6, and 8.7,
respectively (p-trend < 0.001; not shown on tables).
3.2. Propensity score estimation and matching
After performing propensity score matching in the
entire population, overall distribution of propensity
scores was compared between those with higher and
lower plasma calcium levels (Figure 1). Common
support region needed for matching seemed sufficient
for 1:1 matching, and a total of 2153 matched pairs of
Figure 1. Distribution of propensity scores among participants with lower and higher plasma calcium levels. Lower calcium,
plasma calcium <2.37 mmol/L; higher calcium, plasma calcium 2.37 mmol/L.
Plasma calcium and hypertension 85participants were created. After matching, factors that
were significantly different between the lower and
higher plasma calcium groups became either nonsig-
nificant or the difference decreased in size (Table 1).
3.3. Multivariable analysis for incidence of
hypertension with higher level of plasma
calcium
Multivariable analysis using Cox proportional hazards
models based on factors that were significant at baseline
is represented in Table 2. Before propensity score
matching, plasma calcium 2.37 versus <2.37 mmol/L
was associated with significantly higher risk for devel-
oping hypertension (adjusted hazard ratio [HR], 1.29;
95% confidence interval [95%CI], 1.141.47). This
association remained significant after the propensity
score matching (adjusted HR, 1.24; robust 95%CI,
1.071.43).
3.4. Cumulative incidence of hypertension with
higher and lower levels of plasma calcium
With higher level of plasma calcium (2.37 mmol/L),
cumulative incidence of hypertension was significantly
higher as shown by Kaplan-Meier curves both before
and after propensity score matching (Figure 2).
Although the significance was rather attenuated aftermatching, it was still highly significant (log-rank
p Z 0.008).
3.5. Interaction between plasma calcium and
dietary calcium intake
Among participants with higher level of plasma
calcium, development of hypertension during follow-up
was higher among those with the lowest dietary calcium
intake (Q1 vs. Q24, 105/493 [21.3%] vs. 284/1546
[18.4%]), although the difference was not statistically
significant (Figure 3). Logistic regression, including the
interaction term between dietary calcium intake and
plasma calcium, was also not statistically significant
(data not shown).
3.6. Sensitivity of study results to hidden bias
Using the Mantel-Haenszel bounds method, sensi-
tivity analysis showed that the effects of higher plasma
calcium could not be explained away, even at large
values of G (Supplementary Table 2). This shows that
the study result was highly robust to hidden bias.4. Discussion
In this population-based prospective cohort study
various risk factors for hypertension and their
Table 1. Baseline characteristics of participants before and after propensity score matchinga
Characteristics
Before matching (n Z 5560) After matching (n Z 4306)
Lower calciumb Higher calciumc p Lower calciumb Higher calciumc p
Age, years 50.5  8.7 51.5  8.5 <0.001 51.1  0.2 51.0  0.2 0.724
Smoking, n (%) 0.027 0.514
Never 1619 (56.5) 1603 (59.4) 1300 (60.4) 1279 (59.4)
Ever 1245 (43.5) 1093 (40.5) 853 (39.6) 874 (40.6)
Area, n (%) 0.254 0.170
Ansung (rural) 1403 (49.0) 1362 (50.5) 1092 (50.7) 1047 (48.6)
Ansan (urban) 1461 (51.0) 1334 (49.5) 1061 (49.3) 1106 (51.4)
Plasma calcium, mmol/L 2.26  0.0 2.45  0.0 <0.001 2.27  0.0 2.45  0.0 <0.001
Systolic BP, mmHg 113.9  0.2 114.9  0.2 <0.001 114.5  0.2 114.6  0.2 0.675
Serum creatinine, mmol/L 87.0  11.3 88.1  5.7 <0.001 87.0  11.3 87.7  5.0 0.006
Microalbuminuria, n (%) 102 (3.6) 228 (8.5) <0.001 100 (4.6) 103 (4.8) 0.829
Serum glucose, mmol/L 4.72  0.02 4.61  0.03 0.002 4.59  0.03 4.64  0.03 0.212
BMI, kg/m2 24.6  0.1 24.4  0.1 0.011 24.5  0.1 24.5  0.1 0.810
Total cholesterol, mmol/L 4.93  0.02 4.88  0.02 0.031 4.87  0.02 4.89  0.02 0.554
HDL-C, mmol/L 1.18  0.0 1.13  0.0 <0.001 1.17  0.01 1.14  0.01 <0.001
Triacylglyceride, mmol/L 3.68  0.04 4.35  0.05 <0.001 3.82  0.05 4.25  0.06 <0.001
GTP, U/L 29.4  0.9 33.8  1.2 0.003 30.3  1.1 30.7  1.0 0.813
aFactors that were significant in Supplementary Table 1 are shown; bPlasma calcium <2.37 mmol/L; cPlasma calcium 2.37 mmol/L.
Mean  SD unless otherwise stated.
BMI, body mass index; BP, blood pressure; GTP, g-glutamyl transferase; HDL-C, high-density lipoprotein cholesterol.
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analyzed, and positive association of plasma calcium
with incidence of hypertension was shown.
Recently, elevated level of plasma calcium has been
reported to be associated with parameters of metabolic
syndrome and insulin resistance [11,14]. Although the
underlying mechanisms are not fully understood, PTH
seems to play some role, possibly by proliferative effect
on vascular smooth muscle cells contributing to vessel
wall thickening [15] PTH also indirectly increases
vascular smooth muscle intracellular calcium by acti-
vating vitamin D, which results in contraction and
increased peripheral vascular resistance [16,17]. In our
study, serum PTH was not measured; therefore, its role
in development of hypertension could not be analyzed.
However, plasma calcium was significantly associated
with future risk of hypertension, which extends the
previously reported cross-sectional correlation [18e20].
Hypercalcemia has also been shown to induce hyper-
tension in dogs, where intravenous infusion of CaCl2
caused increased mean arterial blood pressure, total
peripheral resistance, and renal vascular resistance [21].Table 2. Multivariable adjusted hazard ratios for hypertension w
matching
No. cases/total Person-years HR
Before matching 1016/5560 25,810 1.42
After matchingc 776/4306 20,016 1.24
aReference, lower plasma calcium (<2.37 mmol/L); bAdjusted for sex, age, alco
plasma glucose, GTP, total cholesterol, HDL-C, and TG; cRobust standard erroAssociations between dietary calcium intake and
blood pressure were reported in some studies [5,22,23],
but not in others [6,7,24]. Overall, there seems a small
degree of BP reduction with increasing dietary intake of
calcium [7]. Since the BP-lowering effect of calcium
supplementation appears small, studies with substantial
heterogeneity in terms of participant characteristics,
measurement of BP outcomes, and dose and method of
calcium supplementation might result in different
conclusions. In our study, the amount of calcium intake
(mean, 485 mg/d) was lower compared with previous
studies, where even higher intake of calcium (mean,
825 mg/d) did not reduce either the blood pressure or the
risk of developing hypertension [24]. Although not
significant in this study, the interaction between the
effects of dietary calcium intake and plasma calcium on
development of hypertension did seem rather conspic-
uous. The amount of calcium intake in our study was
assessed by semi-quantitative food frequency question-
naires [25]. Further studies with higher intake of
calcium and more detailed survey on calcium intake
could reveal more significant findings.ith higher plasma calciuma before and after propensity score
Unadjusted Adjustedb
(95%CI) p HR (95%CI) p
(1.251.61) <0.001 1.29 (1.141.47) <0.001
(1.071.42) 0.003 1.24 (1.071.43) 0.004
hol, smoking status, cohort, baseline SBP, serum creatinine, BMI, fasting
rs used, accounting for clustering of matched pairs.
Figure 2. Kaplan-Meier estimates of cumulative incidence of hypertension.
Plasma calcium and hypertension 87In our study, baseline plasma calcium was positively
associated with higher systolic BP, serum creatinine,
and tendency towards dyslipidemic profile (higher TG
and lower HDL-C), which is consistent with previous
reports [11,26]. Cardiovascular risk factors tend to occur
in clusters, and plasma calcium was already associated
with multiple cardiovascular risk factors at baseline.
To balance the differences between higher and lower
plasma calcium groups, we performed propensity score
matching analysis. Although the differences in serum
creatinine, HDL-C, and TG between the groups
remained significant, they decreased after matching.
Also, there were only a few cases of clinically signifi-
cant levels of azotemia or dyslipidemia that could haveFigure 3. Development of hypertension among participants with h
of dietary calcium intake. Dietary calcium intake quartiles: Q1, <caused hypertension in the higher-plasma calcium
group. By balancing most of the covariates between the
groups, we were able to minimize selection bias and
assess the impact of having higher plasma calcium on
development of hypertension with minimal attribution
of confounding variables. We also adjusted for serum
creatinine and other potential confounding variables in
the final multivariable analysis so as further to minimize
selection bias.
There were several limitations in this study. First, the
follow-up time of 6 years was relatively short, which
could be insufficient for development of a chronic
disease such as hypertension. Second, the serum level of
PTH was not measured. PTH plays a crucial role inigher and lower levels of plasma calcium according to quartiles
301; Q2, 302432; Q3, 433604; Q4, 605 mg/d.
88 J.W. Kim, et alcalcium metabolism, and PTH may have had
a confounder effect. Third, there was no repeat calcium
measurement during follow-up. Initial plasma calcium
levels could merely reflect a snapshot at a particular
time, and long-term effects of such a measurement are
not certain. Fourth, clinical application of the findings of
this paper is limited, since only plasma calcium values
within normal limits were analyzed. Finally, some of
the variables that were significantly different between
higher and lower plasma calcium levels before propen-
sity score matching remained significant even after
matching. Although these variables were adjusted in the
multivariable analysis, they could have caused some
confounding effect.
In conclusion, we showed that a higher level of
plasma calcium was associated with increased incidence
of hypertension. This study also indicated that plasma
calcium levels tend to correlate with other car-
diometabolic risk factors.Acknowledgement
This study was supported by an intramural fund (No.
347-4851-302) of Korea National Institute of Health.Supplementary Material
Supplementary data related to this article can be
found online at doi:10.1016/j.phrp.2011.07.004.References
1. Elliott WJ. Systemic hypertension. Curr Probl Cardiol 2007;32:
201e59.
2. Kubo M, Hata J, Doi Y, et al. Secular trends in the incidence of
and risk factors for ischemic stroke and its subtypes in Japanese
population. Circulation 2008;118:2672e8.
3. Sjol A, Thomsen KK, Schroll M. Secular trends in blood pres-
sure levels in Denmark 1964e1991. Int J Epidemiol 1998;27:
614e22.
4. Jee SH, Appel LJ, Suh I, et al. Prevalence of cardiovascular risk
factors in South Korean adults:results from the Korea Medical
Insurance Corporation (KMIC) Study. Ann Epidemiol 1998;8:
14e21.
5. Weidmann P, Massry SG, Coburn JW, et al. Blood pressure effects
of acute hypercalcemia. Studies in patients with chronic renal
failure. Ann Intern Med 1972;76:741e5.
6. Marone C, Beretta-Piccoli C, Weidmann P. Acute hypercalcemic
hypertension in man: role of hemodynamics, catecholamines, and
renin. Kidney Int 1981;20:92e6.
7. Earll JM, Kurtzman NA, Moser RH. Hypercalcemia and hyper-
tension. Ann Intern Med 1966;64:378e81.8. Kisch ES, Dluhy RG, Williams GH. Regulation of renin release by
calcium and ammonium ions in normal man. J Clin Endocrinol
Metab 1976;43:1343e50.
9. Shackney S, Hasson J. Precipitous fall in serum calcium, hypo-
tension, and acute renal failure after intravenous phosphate
therapy for hypercalcemia. Report of two cases. Ann Intern Med
1967;66:906e16.
10. Llach F, Weidmann P, Reinhart R, et al. Effect of acute and long-
standing hypocalcemia on blood pressure and plasma renin
activity in man. J Clin Endocrinol Metab 1974;38:841e7.
11. Ahlstrom T, Hagstrom E, Larsson A, et al. Correlation between
plasma calcium, parathyroid hormone and the metabolic syndrome
in a community-based cohort of men and women. Clin Endocrinol
(Oxf) 2009;71:673e8.
12. Rosenbaum P, Rubin D. The central role of the propensity score in
observational studies for causal effects. Biometrika 1983;70:
41e55.
13. D’Agostino Jr RB. Propensity score methods for bias reduction in
the comparison of a treatment to a non-randomized control group.
Stat Med 1998;17:2265e81.
14. Hagstrom E, Hellman P, Lundgren E, et al. Serum calcium is
independently associated with insulin sensitivity measured with
euglycaemic-hyperinsulinaemic clamp in a community-based
cohort. Diabetologia 2007;50:317e24.
15. Perkovic V, Hewitson TD, Kelynack KJ, et al. Parathyroid
hormone has a prosclerotic effect on vascular smooth muscle cells.
Kidney Blood Press Res 2003;26:27e33.
16. Zemel MB. Calcium modulation of hypertension and obesity:
mechanisms and implications. J Am Coll Nutr 2001;20:
428e435S. discussion 440e2S.
17. Lind L, Hanni A, Lithell H, et al. Vitamin D is related to blood
pressure and other cardiovascular risk factors in middle-aged men.
Am J Hypertens 1995;8:894e901.
18. Robinson D, Bailey AR, Williams PT. Calcium and blood pres-
sure. Lancet 1982;2:1215e6.
19. Kesteloot H, Geboers J, Van Hoof R. Epidemiological study of the
relationship between calcium and blood pressure. Hypertension
1983;5:II52e6.
20. Folsom AR, Smith CL, Prineas RJ, Grimm Jr RH. Serum calcium
fractions in essential hypertensive and matched normotensive
subjects. Hypertension 1986;8:11e5.
21. Eiam-Ong S, Punsin P, Sitprija V, Chaiyabutr N. Acute
hypercalcemia-induced hypertension: the roles of calcium channel
and alpha-1 adrenergic receptor. J Med Assoc Thai 2004;87:410e8.
22. van den Hoogen PC, Feskens EJ, Nagelkerke NJ, et al. The rela-
tion between blood pressure and mortality due to coronary heart
disease among men in different parts of the world. Seven Coun-
tries Study Research Group. N Engl J Med 2000;342:1e8.
23. Lind L, Skarfors E, Berglund L, et al. Serum calcium: a new,
independent, prospective risk factor for myocardial infarction in
middle-aged men followed for 18 years. J Clin Epidemiol 1997;
50:967e73.
24. Margolis KL, Ray RM, Van Horn L, et al. Effect of calcium and
vitamin D supplementation on blood pressure: the Women’s Health
Initiative Randomized Trial. Hypertension 2008;52:847e55.
25. Third Korea National Health and Nutrition Examination Survey
(KNHANES III); 2006.
26. Kesteloot H, Joossens JV. Relationship of serum sodium, potas-
sium, calcium, and phosphorus with blood pressure. Belgian
Interuniversity Research on Nutrition and Health. Hypertension
1988;12:589e93.
